KUCHING, Nov 25 — Very promising results have been achieved in clinical trials using the improved Calanolide A compound derived from the Bintangor tree (Calophyllum lanigerum var austrocoriaceum) in the treatment of HIV.
State Assistant Minister of Science Research and Biotechnology Dr Annuar Rapaee said the trials were done in the Sarawak General Hosptial here and in Penang.
“With these results, the state Crop Research and Unit Application (Craun) has prepared a paper to the state cabinet and to request for funds to appoint a consultant to conduct market intelligence and out-licensing exercise,” he said.
He was replying to supplementary questions from Hazland Abang Hipni (BN-Demak Laut) at the state Legislative Assembly sitting here today.
Craun, which is managing the Calanolide A project on behalf of the state government, had also filed for a product patent, he said.
Dr Annuar said it would extend market protection for the Calanolide A extracts until 2030.
Meanwhile he said the state government was planning to establish a body called the Sarawak Research Council to spearhead organisation and management of research and development as well as coordinate research activities in the state.
He said Sarawak strategies and directions for its science research and bio- industries were in line with the National Biotech Policy (NBP) as well as its own Sarawak Socio-Economic Transformation Plan (SETP 2006-2030). — Bernama
